Navigation Links
New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence
Date:11/9/2007

6 month results from long term durability study presented at Western

Section meeting of the American Urological Association

NEWARK, Calif., Nov. 9 /PRNewswire/ -- Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that six month data from its post-market, prospective open label study to evaluate the long term durability of the Renessa(R) treatment for stress urinary incontinence (SUI) in women was presented at the Western Section meeting of the American Urological Association (AUA). A total of 137 women in the trial have been treated at 13 different sites across the United States. The patients will be followed for three years post-treatment.

Denise Elser, M.D., a urogynecologist practicing in Oak Lawn, Illinois and the principal investigator in the trial, presented the data in Scottsdale, AZ. "The non-surgical Renessa procedure offers women suffering from the isolating effects of SUI a safe, effective alternative between conservative treatments such as Kegel exercises and biofeedback, and more invasive surgical therapies," Dr. Elser said. "Women are looking for an alternative to exercise and surgery. My patients and I have been very pleased with the safety and results of this noninvasive treatment," she continued. The trial results will also be presented during a poster session at the upcoming Global Congress of Minimally Invasive Gynecology in Washington, DC.

Highlights of the six month results include:

-- 74% of women showed an improvement in their symptoms with 63% of women

reducing their episodes to less than half

-- 74% of women reported improvement in their quality of life

"This multi-center three year prospective trial is expected to confirm the outcomes seen in our previous U.S. Pivotal Trial," said Charles S. Carignan, M.D., Chief Medical Officer of Novasys Medical. "The six month results so far not only validate our earlier studies, but outcomes
'/>"/>

SOURCE Novasys Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...rch report is available in its catalogue: ,, U...recasts to 2015 ,, http://www.reportlinker.co...lysis-and-Forecasts-to-2015.html ,, United Sta...o 2015 ,, Summary ,, This report is an ess...
(Date:11/25/2009)..., , UNION CITY, Calif., Nov. 25 /PRNewswire-F...cal products company manufacturing point-of-care b...Severson, chairman and chief executive officer, wi... Care Conference on Wednesday, December 2, 2009 at...New York Palace Hotel in New York City. ,, Abo...
(Date:11/25/2009)..., , WALTHAM, Mass., Nov. 25 /PRNewswir..., the global authority on medical technology marke...r trauma fixation devices will continue to see rap...ent economic slowdown. MRG,s US Markets for Traum...ll remain highly dynamic over the next five years,...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 1CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 2CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 3Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts 28TM 29 14592 1Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts 28TM 29 14592 2Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts 28TM 29 14592 3Volcano Corporation Schedules Third Quarter Conference Call Webcast 5690 1Volcano Corporation Schedules Third Quarter Conference Call Webcast 5690 2
(Date:11/29/2009)...gin to form between brain cells almost immediately... published this week in Nature . Led by researche...e study involved detailed observations of the rewi... motor learning. , The researchers studied mice ...t a seed. They observed rapid growth of structures...
(Date:11/29/2009)...r boosts urine production, experts say , ... wake up during the night to urinate shouldn,t aut..., a breathing-related sleep disorder, could be the...rination, or nocturia, is comparable to loud snori...rder in which soft tissue in the throat blocks the...
(Date:11/28/2009)...wire/ -- Get ready for advanced visualization t... when Siemens introduces syngo. via(1) at...f the Radiological Society of North America (RSNA)... (Booth #825, East Building/Lakeside Center, Hall ...new imaging software for multimodality reading of ...
(Date:11/27/2009)...PRNewswire-FirstCall/ -- GSI Group Inc. (Pink Shee... technology products and semiconductor systems, to...y,s shareholders has been scheduled for Friday, Ap...g will be announced in due course. As previously ...ce from Stephen Bershad, a holder of greater than ...
(Date:11/27/2009)...ewswire-FirstCall/ -- The Gymboree Corporation (Na...O, will present at the NASDAQ OMX 23rd Investor Pr... London, England, on Wednesday, December 2, 2009, ...cast of The Gymboree Corporation,s presentation ov..., click on "Our Company" at the bottom of the page...
Breaking Medicine News(10 mins):Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2
...Bush administration sought on Tuesday to overturn ... to apply for federal funding without signing// an...ing. One of the groups, DKT International Inc.,...ar DKT sued the U.S. Agency for International Deve...
...sts of creams, facemasks and peelers in packaging ...ar//, the battle against the wrinkles that come in...rface of the human skin. The latest weapons, ...st layer of the skin, with the aim of smoothing ou...
...s implicated in 85 percent of colon cancer (carcin...at University //of Utah's Huntsman Cancer Institut...t against colon cancers in the future. Rese... a molecule called C-Terminal Binding Protein Thes...
...dentified a gene, whose presence might enhance the...t cancer. // British researchers have made it...P1 gene, carry twice the normal risk of being affl...ignificantly heightens the risk. Further, sci...
...veals that moderate intensity regular exercise can...ng radiation treatment.// This study was publi...eer-reviewed journal of the American Cancer Societ...on treatment. On the other hand, obvious decrease ...
... Mukesh Haikerwal, said today the AMA still has se...nselling Medicare item//, but is relieved that the...ns than the original. The Government previous...bout their pregnancy, a process that the AMA warne...
Other Medicine News:Health News:Do Anti-wrinkle Cosmetics Really Work? 2Health News:Novel Techniques to Tackle Colon Cancer 2Health News:Exercise alleviates Anemia in Breast cancer patients 2Health News:Revised Pregnancy Counselling Item Still Flawed 2
... Xtra, and Maximum ACT introducers represent the l...ntroducers in the world. They are recognized as th...entional cardiology and electrophysiology procedur...therectomy, temporary pacing, endomyocardial biops...
Preface Braided Guiding Sheath
... Xtra, and Maximum ACT introducers represent the l...ntroducers in the world. They are recognized as th...entional cardiology and electrophysiology procedur...therectomy, temporary pacing, endomyocardial biops...
Bx Velocity Rx with Hepacoat
Medicine Products: